Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients

Published:2017-12-12 Issue:2 Volume:48 Page:196-204
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Jörg L.¹^ORCID,Pecaric-Petkovic T.²,Reichenbach S.¹³,Coslovsky M.³,Stalder O.³,Pichler W.²,Hausmann O.¹²

Affiliation:

1. Department of Rheumatology, Immunology and Allergology, Inselspital; Bern University Hospital; University of Bern; Bern Switzerland

2. Adverse Drug Reactions, Analysis and Consulting; ADR-AC GmbH; Bern Switzerland

3. Clinical Trial Unit; University of Bern; Bern Switzerland

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.13066/fullpdf

Reference34 articles.

1. Epidemiology of urticaria: a representative cross-sectional population survey;Zuberbier;Clin Exp Dermatol,2010

2. The diagnosis and management of acute and chronic urticaria: 2014 update;Bernstein;J Allergy Clin Immunol,2014

3. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review;Kozel;J Am Acad Dermatol,2003

4. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria;Staevska;J Allergy Clin Immunol,2010

5. Autoimmune urticaria;Grattan;Immunol Allergy Clin North Am,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta‐analysis;Skin Research and Technology;2024-05

2. Research hotspots in urticaria: A bibliometric study of the top 100 most cited articles;Skin Research and Technology;2024-05

3. Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis;World Allergy Organization Journal;2024-04

4. Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial;British Journal of Dermatology;2024-02-17

5. Temporal, Drug Dose, and Sample Size Trends in the Efficacy of Omalizumab for Chronic Spontaneous Urticaria: A Cumulative Meta‐Analysis;Journal of Clinical Pharmacy and Therapeutics;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3